Motus GI (MOTS) Competitors

Nemaura Medical (NASDAQ:NMRD) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

Which has more risk and volatility, NMRD or MOTS?

Nemaura Medical has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Motus GI has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

Do institutionals & insiders hold more shares of NMRD or MOTS?

4.4% of Nemaura Medical shares are owned by institutional investors. Comparatively, 20.1% of Motus GI shares are owned by institutional investors. 40.4% of Nemaura Medical shares are owned by insiders. Comparatively, 0.3% of Motus GI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Does the media prefer NMRD or MOTS?

In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company	Overall Sentiment
Nemaura Medical	Neutral
Motus GI	Neutral

Is NMRD or MOTS more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Nemaura Medical	N/A	N/A	N/A
Motus GI	N/A	N/A	N/A

Which has higher valuation & earnings, NMRD or MOTS?

Motus GI has higher revenue and earnings than Nemaura Medical. Motus GI is trading at a lower price-to-earnings ratio than Nemaura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nemaura Medical	$3.02K	0.00	-$14.14M	-$0.39	N/A
Motus GI	$319K	0.00	-$12.87M	-$15.64	0.00

Summary

Motus GI beats Nemaura Medical on 5 of the 7 factors compared between the two stocks.